Engflag

Vocalzone

Quick links to important sections

Vocalzone

Vocalzone_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vocalzone

Property Description
Active Ingredient Menthol, Liquorice, Myrrh, Peppermint Oil
Form Pastille (oromucosal lozenge)
Pharmacological Class Local Anesthetic, Demulcent, Astringent
Common Use Symptomatic relief of throat irritation and hoarseness
Origin Traditional Herbal Medicinal Product

What Type of Medicine is Vocalzone?

Vocalzone is defined as an oromucosal pastille, which is a specialized, non-prescription compound formulation intended for localized application to the throat and pharynx. This dosage form is engineered to dissolve slowly, ensuring the active constituents are released gradually across the irritated oromucosal surface. The preparation's functional identity is rooted in its high-level pharmacological classification, delivering effects that combine local anesthetic action—primarily via Menthol—with the demulcent and astringent properties of its herbal components. Menthol is traditionally used for the symptomatic relief of throat complaints due to its cooling effect. This property is providing immediate, localized sensory relief.

Composition and Origin: Is Vocalzone a Natural Formulation?

The pastille is classified as a Traditional herbal medicinal product, relying on a fixed combination of ingredients primarily sourced from natural origins, a key differentiating factor from many single-ingredient synthetic lozenges. The core active components include Menthol, derived from Peppermint Oil (Mentha piperita), and extracts from Liquorice (Glycyrrhiza glabra) root and Myrrh (Commiphora species) tincture. The inclusion of Liquorice provides a demulcent action, which coats and soothes the irritated lining. Myrrh further contributes a mild astringent and antiseptic property to the compound formulation. This specialized herbal blend differentiates its sensory and mechanical effects from simpler aromatic preparations.

General Purpose and Vocal Relief

The overarching purpose of the Vocalzone pastille is to offer symptomatic relief for general throat irritation and hoarseness. While available to the general public, the product is distinctively positioned for, and utilized by, vocal professionals—such as singers and public speakers—to maintain comfort in a strained throat. By combining Menthol's rapid, cooling action with the protective, soothing action provided by Liquorice, the preparation delivers a local palliative effect that supports the throat's well-being without treating any underlying medical condition.

What side effects are possible with Vocalzone?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety characteristics for Vocalzone pastilles, strictly based on regulatory documents from government authorities such as the MHRA.

Adverse Reactions and System-Organ Classification

The frequency of most documented adverse effects is typically Not Known or Not Specified in the regulatory consumer information for this product. The key focus in the safety profile is on the risk of severe hypersensitivity reactions (Immune system disorders). These serious adverse reactions, which require immediate medical attention, are documented as including difficulty in breathing, swelling of the face, neck, tongue, or throat, and the appearance of a rash (Skin and subcutaneous tissue disorders).

Separately, the ingestion of polyols (sugar alcohols) in the sugar-free variants is associated with a specific dose-related effect on the Gastrointestinal system. Excessive consumption of these variants may cause a laxative effect.

Population-Specific Safety Constraints

The official label defines specific limitations for certain user groups and pre-existing conditions:

Population Group Safety Constraint (Official Regulatory Statement)
Children under 12 years The pastilles are not suitable for use in this age group.
Pregnancy/Breastfeeding Consultation with a doctor or pharmacist is advised prior to use.
Sugar Intolerances Individuals with an intolerance to sucrose and glucose must consult a doctor before using the Original and Honey & Lemon variants.
Hypertension Individuals suffering from hypertension should avoid excessive consumption due to the Liquorice component.

Use of the pastilles is contraindicated in any individual with a known allergy or hypersensitivity to any of the ingredients.

The regulatory safety structure focuses primarily on identifying and communicating critical, low-frequency, severe allergic risks and establishing clear restrictions for specific populations and consumption limits.

Overdose and Emergency Response

The official regulatory profile for this pastille addresses the risks associated with excessive ingestion of its active components. Acute systemic exposure to high quantities of Menthol may lead to documented manifestations such as nausea, vomiting, dizziness, and tremors. Severe outcomes linked to high-level Menthol exposure include central nervous system effects such as convulsions, seizures, and coma.

Separately, the toxicity profile addresses the effects of prolonged, high-dose consumption of the Liquorice component. This chronic exposure may result in a documented condition resembling Pseudohyperaldosteronism, characterized by severe electrolyte disturbances, notably hypokalemia (low potassium) and arterial hypertension. These imbalances can escalate to life-threatening complications, including cardiac arrhythmias. Patients with pre-existing conditions like hypertension or kidney disease are noted to have increased sensitivity to these adverse effects.

Treatment is strictly symptomatic and supportive, as no specific antidote is known for Menthol poisoning. Supportive interventions include monitoring vital signs, potassium replacement, and management of hypertension. Seek immediate medical attention for the onset of any severe systemic symptoms or the development of a severe allergic reaction, such as swelling or difficulty breathing, as mandated by regulatory documents.

Therapeutic Uses of Vocalzone

Vocalzone is commonly used to provide symptomatic relief across key domains of minor throat and vocal discomfort, and provides supportive relief when symptoms interfere with routine activities. The active ingredients are applied in contexts where additional symptomatic support is needed, consistent with the use of similar agents for minor irritation and discomfort.

Managing Hoarseness and Vocal Strain

This preparation is commonly used across conditions characterized by periods of heightened symptoms related to temporary vocal strain, fatigue, or hoarseness, relevant in contexts marked by increased discomfort or tension for vocal-dependent professionals. The primary symptom areas include hoarseness, vocal fatigue, and pharyngeal irritation. It offers a soothing, palliative effect that helps support greater comfort and vocal clarity during and after intensive voice use, assists with maintaining functional stability when symptoms are more noticeable.

“Applied in scenarios where additional management of discomfort is required, the preparation supports general well-being during symptomatic phases.”

Easing Pharyngeal Irritation and Dryness

Vocalzone helps address symptom clusters related to minor pharyngeal irritation, including the sensations of a scratchy throat or persistent dryness often associated with environmental factors. The medication provides supportive relief by addressing the sensation of dryness, contributing to easing the overall symptom load and may help patients cope more steadily with symptom fluctuations.

Quick Fact: Relief for Vocal Discomfort
Commonly used by: Vocal Professionals (singers, speakers)
Symptom focus: Hoarseness, Vocal Strain, Scratchy Throat

Regulatory References

  1. DailyMed overview of Menthol/Pectin Lozenge Use

Eligibility and Restrictions for Use

Who can and cannot use Vocalzone?

The eligibility for Vocalzone Throat Pastilles is determined by official labeling, which defines who may safely use the medicine and under what conditions. The following is based strictly on regulatory-aligned consumer information.

Approved and Non-Approved Populations

Classification Eligible Groups Non-Eligible Groups (Contraindicated)
Age Group Adults and The Elderly Children under 12 years
Pediatric Use Children 12 years and older Not suitable for use below age 12

Restrictions and Conditions for Use

Use is restricted or requires consultation in several situations:

  • Hypersensitivity: The pastilles must not be taken by anyone with a known allergy to any of the ingredients, including Menthol, Liquorice, Myrrh, or Peppermint Oil.
  • Pregnancy and Lactation: Women who are pregnant or breastfeeding are advised to consult a doctor or pharmacist before use, as the product is not recommended for this population.
  • Sugar Intolerance: Individuals with an intolerance to certain sugars (sucrose and glucose) should contact a doctor before using the standard formula pastilles, as they contain these excipients.
  • Hypertension: Due to the Liquorice content, individuals with high blood pressure should avoid excessive consumption of the pastilles, a common restriction for liquorice-containing products.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Vocalzone throat pastilles indicates that no known drug interactions have been established or documented with this product. The available product information does not list any specific interacting medicinal products or product categories that require avoidance or dosage modification due to a clinically significant pharmacokinetic or pharmacodynamic mechanism.

Despite the absence of specific known interactions, the official regulatory documents recommend a procedural precaution: users who are currently taking any other medicines should consult a pharmacist or doctor before using the pastilles. This is a general advisory included to ensure comprehensive safety in the context of co-administration.

Summary of Interaction Profile

Interaction Domain Official Regulatory Statement Practical Implication
Specific Interacting Medicines None explicitly listed or identified. No mandatory restrictions based on co-administration with specific drugs.
Mechanistic Basis No specific pharmacokinetic or pharmacodynamic mechanisms described. Interaction profile is considered clear of established conflicts.
Procedural Constraint Advised to consult a doctor or pharmacist if taking other medicines. Standard due diligence is required prior to co-administration.

This interaction profile is characterized by the explicit regulatory statement of no known drug interactions, structuring the official advice around a general precautionary consultation rather than specific drug interaction rules.

Mechanism of Action

Peripheral Sensory Counter-Irritation

This localized mechanism is driven by Menthol, which functions as an agonist at the Transient Receptor Potential Cation Channel Subfamily M Member 8 (TRPM8) located on peripheral sensory neurons in the pharynx. Activation of this cold-sensing receptor initiates a rapid neural signal that neurologically masks and overrides existing peripheral nociceptive or mechano-sensory signals. This modulation effectively alters somatosensory perception at the earliest point of stimulation, leading to a swift physiological alteration of neural signaling balance.

Oromucosal Physical Shielding

This complementary domain involves the mechanical actions of Liquorice and Myrrh extracts on the tissue surface. The Liquorice components form a demulcent film that acts as a physical barrier, reducing physical friction and mechanical stimulation of exposed nerve endings. Myrrh further contributes to local tissue stabilization through a mild astringent effect that tones the mucosa, reducing localized fluid exudation and contributing to the adherence of the demulcent film. This combined physical shielding maintains the anti-friction mechanism against mechanical stimuli.

Dosage and Administration Information

How to Use Vocalzone Throat Pastilles

The following instructions outline the administration of Vocalzone Throat Pastilles. This section defines the method, dosage, and frequency, excluding information related to therapeutic benefits, safety, or drug interactions.

Administration Protocol

Usage Entity Instruction
Route of Administration Oral / Oromucosal. The pastille must be dissolved slowly in the mouth.
Dosage Form Pastille (lozenge).
Standard Single Dose One (1) pastille per dose.
Dosing Frequency Repeat every two (2) hours, if needed.
Maximum Use Do not exceed the maximum recommended dose per day.
Age Restriction Suitable for adults and children aged 12 years and over. Not recommended for children under 12 years.

Procedural Steps

The use of Vocalzone is defined by the following sequence:

  1. Place a single pastille in the mouth.
  2. Allow the pastille to dissolve slowly in the mouth.
  3. While the pastille is dissolving, inhale deeply.
  4. Do not chew or swallow the pastille whole.
  5. Wait a minimum of two hours before taking the next dose, if required.

These guidelines establish the method and schedule for the product's use, ensuring adherence to the labeled administration technique and dosage limits.

Recent Clinical Evidence

Research evidence / Overview of studies for Vocalzone

The Regulatory Foundation: Traditional Herbal Registration

Vocalzone is defined by regulators as a Traditional Herbal Medicinal Product (THMP) in certain territories. This classification helps define the research documentation that underpins the product's authorization. Unlike some medicines that require clinical trials to demonstrate effectiveness, the authorization for a THMP is granted on the basis of long-standing use—meaning the product and its components have a documented history of use for their intended purpose for a period exceeding 30 years.

This traditional evidence helps show what has been observed so far about the pastille's use in daily life, establishing a detailed history of use and patient-reported outcomes describing perceived discomfort. It means the evidence for the combination product is rooted in historical documentation and experiential data, and its claims are not based on modern, full-scale clinical trials designed to prove effectiveness.

Research Base for Symptomatic Relief of Throat Irritation

Research has explored the product's authorized indication for symptomatic relief of throat irritation and dryness. The evidence base for this indication is dual: it includes the traditional use documentation for the final pastille combination, and it also includes controlled studies that research the product's individual active ingredients, such as Menthol and Liquorice.

Research was conducted on the ingredients, often applied in studies examining patient-reported experiences related to episodic symptom patterns. For instance, Liquorice has been studied in research examining outcomes related to physical discomfort in specific medical settings. These trials contribute to the broader evidence landscape describing how patients reported their experience when using similar active components.

Research Gaps and Uncertainty in the Evidence

While a foundation of traditional use is established, there are areas where research is still emerging. A primary limitation is that the final combination product has not been evaluated in modern, full-scale Randomized Controlled Trials (RCTs) designed to formally establish efficacy for general throat irritation, as this is not a regulatory requirement for a THMP.

This highlights a limitation where comparative evidence is limited—there is no available research that directly compares the finished Vocalzone pastille to other lozenges in controlled trials. Furthermore, data for certain groups, such as children or older adults, remain insufficient, and the results apply only to the populations studied in the ingredient-specific research. Evidence contributes to the broader evidence landscape but research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Comparative study of Menthol lozenges and Saline gargle in prevention of post-operative sore throat in children: A randomised controlled trial
  2. Menthol and Pectin (Cough Suppressant and Oral Anesthetic) Drug Labeling

Frequently Asked Questions (FAQ)

Common questions about Vocalzone (FAQ)

Q: What are the active ingredients in Vocalzone and what are they used for?

According to the official product information, the active ingredients in Vocalzone are menthol, peppermint oil, and myrrh. Menthol and peppermint oil are traditionally used as mild decongestants and oral analgesics, while myrrh is used as an astringent. These ingredients are included to provide symptomatic relief for catarrh, dry and irritated throats, and hoarseness.

Q: Are there any age restrictions for using Vocalzone products?

Regulatory documents state that Vocalzone should not be given to children under 12 years of age. This recommendation is based on the available product safety information and is a standard guideline for this specific formulation. Patients are advised to always check the accompanying leaflet for the most current guidance on age restrictions.

Q: Can I use Vocalzone if I am currently pregnant or breastfeeding?

Official product information advises that Vocalzone is not recommended for use during pregnancy or while breastfeeding. This is a cautionary measure, as specific safety data regarding its use in these situations may be limited. Consulting the product leaflet and following the current recommendations are important steps for all users.

Q: Does Vocalzone contain any ingredients that might affect people with allergies or sensitivities?

Studies and official information indicate that Vocalzone contains several components that may cause allergic reactions or sensitivities in some individuals. Specifically, the product contains a small amount of E124 (Ponceau 4R), which can trigger an allergic type of reaction, including asthma. Additionally, it contains sucrose and liquid glucose, which are important considerations for individuals with certain sugar intolerances or diabetes.

Q: How should Vocalzone lozenges be used?

According to the official product instructions, Vocalzone lozenges are designed to be slowly dissolved in the mouth. They should not be swallowed whole or chewed to ensure the active ingredients are released gradually for their local effect on the throat. Users should refer to the specific frequency and duration guidelines provided on the packet.

Q: What should I do if my symptoms do not improve after using Vocalzone?

Official product guidance indicates that medical advice should be sought if symptoms persist after a few days of using Vocalzone. If symptoms worsen or new symptoms develop while using the product, consulting a healthcare professional is advised. Vocalzone is intended for symptomatic, short-term relief.

How should Vocalzone be stored and disposed of?

Official Storage and Disposal Requirements

All storage and handling instructions for Vocalzone Throat Pastilles are derived directly from regulatory documentation to maintain product quality and ensure safety.

Storage Conditions

Vocalzone must be stored at a temperature strictly below 25 C in a cool, dry place. To maintain product integrity, the pastilles must not be used after the expiry date printed on the packaging. The product must be stored in a manner that ensures it is kept out of the reach and sight of children.

Disposal Instructions

Unused or expired medicines, including Vocalzone, must not be thrown away via wastewater or household waste. Disposal should be handled in accordance with local environmental regulations, typically by returning the product to a pharmacy for safe handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vocalzone found in:

A-Z Index: